Literature DB >> 22297041

Acute intermittent hypoxia-induced expression of brain-derived neurotrophic factor is disrupted in the brainstem of methyl-CpG-binding protein 2 null mice.

A Vermehren-Schmaedick1, V K Jenkins, S J Knopp, A Balkowiec, J M Bissonnette.   

Abstract

Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the transcription factor methyl-CpG-binding protein 2 (MeCP2). One of its targets is the gene encoding brain-derived neurotrophic factor (bdnf). In vitro studies using cultured neurons have produced conflicting results with respect to the role of MeCP2 in BDNF expression. Acute intermittent hypoxia (AIH) induces plasticity in the respiratory system characterized by long-term facilitation of phrenic nerve amplitude. This paradigm induces an increase in BDNF protein. We hypothesized that AIH leads to augmentation of BDNF transcription in respiratory-related areas of the brainstem and that MeCP2 is necessary for this process. Wild-type and mecp2 null (mecp2(-/y)) mice were subjected to three 5-min episodes of exposure to 8% O(2)/4% CO(2)/88% N(2), delivered at 5-min intervals. Normoxia control wild-type and mecp2 null mice were exposed to room air for the total length of time, that is, 30 min. Following a recovery in room air, the pons and medulla were rapidly removed. Expression of BDNF protein and transcripts were determined by ELISA and quantitative PCR, respectively. AIH induced a significant increase in BDNF protein in the pons and medulla, and in mRNA transcript levels in the pons of wild-type animals. In contrast, there were no significant changes in either BDNF protein or transcripts in the pons or medulla of mice lacking MeCP2. The results indicate that MeCP2 is required for regulation of BDNF expression by acute intermittent hypoxia in vivo.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22297041      PMCID: PMC3293990          DOI: 10.1016/j.neuroscience.2012.01.017

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  41 in total

1.  A bird's-eye view of MeCP2 binding.

Authors:  Sonia Cohen; Michael E Greenberg
Journal:  Mol Cell       Date:  2010-02-26       Impact factor: 17.970

2.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.

Authors:  J Guy; B Hendrich; M Holmes; J E Martin; A Bird
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

3.  Levels of hypoxanthine phosphoribosyltransferase RNA in human cells.

Authors:  A M Steen; H Luthman; D Hellgren; B Lambert
Journal:  Exp Cell Res       Date:  1990-02       Impact factor: 3.905

4.  The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.

Authors:  Qiang Chang; Gargi Khare; Vardhan Dani; Sacha Nelson; Rudolf Jaenisch
Journal:  Neuron       Date:  2006-02-02       Impact factor: 17.173

5.  Expression of functional tyrosine kinase B receptors by rhythmically active respiratory neurons in the pre-Bötzinger complex of neonatal mice.

Authors:  Muriel Thoby-Brisson; Bruno Cauli; Jean Champagnat; Gilles Fortin; David M Katz
Journal:  J Neurosci       Date:  2003-08-20       Impact factor: 6.167

6.  Brain-derived neurotrophic factor enhances fetal respiratory rhythm frequency in the mouse preBötzinger complex in vitro.

Authors:  Julien Bouvier; Sandra Autran; Nathalie Dehorter; David M Katz; Jean Champagnat; Gilles Fortin; Muriel Thoby-Brisson
Journal:  Eur J Neurosci       Date:  2008-08       Impact factor: 3.386

7.  Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome.

Authors:  Michael Ogier; Hong Wang; Elizabeth Hong; Qifang Wang; Michael E Greenberg; David M Katz
Journal:  J Neurosci       Date:  2007-10-03       Impact factor: 6.167

8.  BDNF supports mammalian chemoafferent neurons in vitro and following peripheral target removal in vivo.

Authors:  T Hertzberg; G Fan; J C Finley; J T Erickson; D M Katz
Journal:  Dev Biol       Date:  1994-12       Impact factor: 3.582

9.  The methyl-CpG-binding protein MeCP2 and neurological disease.

Authors:  Adrian Bird
Journal:  Biochem Soc Trans       Date:  2008-08       Impact factor: 5.407

10.  Developmental changes in the BDNF-induced modulation of inhibitory synaptic transmission in the Kölliker-Fuse nucleus of rat.

Authors:  Miriam Kron; Weiqi Zhang; Mathias Dutschmann
Journal:  Eur J Neurosci       Date:  2007-12-04       Impact factor: 3.386

View more
  11 in total

1.  BDNF rs6265 methylation and genotype interact on risk for schizophrenia.

Authors:  Gianluca Ursini; Tommaso Cavalleri; Leonardo Fazio; Tiziana Angrisano; Luisa Iacovelli; Annamaria Porcelli; Giancarlo Maddalena; Giovanna Punzi; Marina Mancini; Barbara Gelao; Raffaella Romano; Rita Masellis; Francesca Calabrese; Antonio Rampino; Paolo Taurisano; Annabella Di Giorgio; Simona Keller; Letizia Tarantini; Lorenzo Sinibaldi; Tiziana Quarto; Teresa Popolizio; Grazia Caforio; Giuseppe Blasi; Marco A Riva; Antonio De Blasi; Lorenzo Chiariotti; Valentina Bollati; Alessandro Bertolino
Journal:  Epigenetics       Date:  2016-02-18       Impact factor: 4.528

Review 2.  Association between brain-derived neurotrophic factor levels and obstructive sleep apnea: a systematic review and meta-analysis.

Authors:  Amirmohammad Khalaji; Amir Hossein Behnoush; Parnian Shobeiri; Behrad Saeedian; Antonio L Teixeira; Nima Rezaei
Journal:  Sleep Breath       Date:  2022-09-17       Impact factor: 2.655

3.  Repetitive acute intermittent hypoxia does not promote generalized inflammatory gene expression in the rat CNS.

Authors:  Megan E Peters; Rebecca S Kimyon; Gordon S Mitchell; Jyoti J Watters
Journal:  Respir Physiol Neurobiol       Date:  2015-07-26       Impact factor: 1.931

Review 4.  Breathing challenges in Rett syndrome: lessons learned from humans and animal models.

Authors:  Jan-Marino Ramirez; Christopher Scott Ward; Jeffrey Lorenz Neul
Journal:  Respir Physiol Neurobiol       Date:  2013-06-28       Impact factor: 1.931

Review 5.  Neurochemistry of the Kölliker-Fuse nucleus from a respiratory perspective.

Authors:  Adrienn G Varga; Sebastian N Maletz; Jordan T Bateman; Brandon T Reid; Erica S Levitt
Journal:  J Neurochem       Date:  2020-06-10       Impact factor: 5.546

6.  Daily Intermittent Normobaric Hypoxia Over 2 Weeks Reduces BDNF Plasma Levels in Young Adults - A Randomized Controlled Feasibility Study.

Authors:  Andreas Becke; Patrick Müller; Milos Dordevic; Volkmar Lessmann; Tanja Brigadski; Notger G Müller
Journal:  Front Physiol       Date:  2018-10-01       Impact factor: 4.566

7.  The evaluation of serum brain-derived neurotrophic factor and neurofilament light chain levels in patients with obstructive sleep apnea syndrome.

Authors:  Burak Arslan; Rabia Şemsi; Ayşe İriz; Aylin Sepici Dinçel
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-10-20

8.  The Role of Brain-Derived Neurotrophic Factor in Obstructive Sleep Apnea and Endothelial Function in a Pediatric Population With Obesity.

Authors:  Sanae Makhout; Eline Vermeiren; Karolien Van De Maele; Luc Bruyndonckx; Benedicte Y De Winter; Kim Van Hoorenbeeck; Stijn L Verhulst; Annelies Van Eyck
Journal:  Front Med (Lausanne)       Date:  2022-01-20

9.  Chronic Intermittent Hypoxia-Induced Aberrant Neural Activities in the Hippocampus of Male Rats Revealed by Long-Term in vivo Recording.

Authors:  Linhao Xu; Qian Li; Ya Ke; Wing-Ho Yung
Journal:  Front Cell Neurosci       Date:  2022-01-21       Impact factor: 5.505

10.  Protective role of brain derived neurotrophic factor (BDNF) in obstructive sleep apnea syndrome (OSAS) patients.

Authors:  Krisstopher Richard Flores; Fausta Viccaro; Mauro Aquilini; Stefania Scarpino; Francesco Ronchetti; Rita Mancini; Arianna Di Napoli; Davide Scozzi; Alberto Ricci
Journal:  PLoS One       Date:  2020-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.